HYPOCHOLESTEROLAEMIA AND INCREASED ELIMINATION OF LOW-DENSITY LIPOPROTEINS IN METASTATIC CANCER OF THE PROSTATE
- 1 November 1989
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 334 (8673), 1178-1180
- https://doi.org/10.1016/s0140-6736(89)91790-x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Estrogen-induced gallstone formation in males. Relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma.JCI Insight, 1989
- Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma.JCI Insight, 1989
- This article concludes the series, which will be published later in book form. PEPTIDE REGULATORY FACTORS AND MALIGNANCYThe Lancet, 1989
- Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention TrialPublished by American Medical Association (AMA) ,1987
- Content of low density lipoprotein receptors in breast cancer tissue related to survival of patients.BMJ, 1986
- HYPOCHOLESTEROLAEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOUR CELLS: EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKAEMIAThe Lancet, 1985
- Selective uptake of a toxic lipophilic anthracycline derivative by the low density lipoprotein receptor pathway in cultured fibroblastsJournal of Medicinal Chemistry, 1985
- Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.JCI Insight, 1982
- PLASMA LIPIDS AND MORTALITY: A SOURCE OF ERRORThe Lancet, 1980
- Cytologic Malignancy Grading of Prostatic Carcinoma by Transrectal Aspiration Biopsy:A Five-year Follow-up Study of 469 Hormone-treated PatientsScandinavian Journal of Urology and Nephrology, 1971